Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study.

Autor: Yubero, Alfonso1 (AUTHOR) ayuberoe@salud.aragon.es, Barquín, Aranzazu2 (AUTHOR), Estévez, Purificación3 (AUTHOR), Pajares, Bella4 (AUTHOR), Sánchez, Luisa5 (AUTHOR), Reche, Piedad6 (AUTHOR), Alarcón, Jesús7 (AUTHOR), Calzas, Julia8 (AUTHOR), Gaba, Lydia9 (AUTHOR), Fuentes, José10 (AUTHOR), Santaballa, Ana11 (AUTHOR), Salvador, Carmen12 (AUTHOR), Manso, Luis13 (AUTHOR), Herrero, Ana14 (AUTHOR), Taus, Álvaro15 (AUTHOR), Márquez, Raúl16 (AUTHOR), Madani, Julia17 (AUTHOR), Merino, María18 (AUTHOR), Marquina, Gloria19 (AUTHOR), Casado, Victoria20 (AUTHOR)
Zdroj: BMC Cancer. 11/8/2022, Vol. 22 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje